Home GPCR & G Protein CCK receptor

CCK receptor

Other GPCR & G Protein Related Inhibitors

Hedgehog/Smoothened PKA CGRP Receptor Endothelin Receptor S1P Receptor Cannabinoid Receptor SGLT Opioid Receptor GPR CCR

Isoform-selective Products

Cat.No. Product Name Information Product Use Citations Product Validations
S2032 Rebamipide Rebamipide (OPC-12759,Proamipide) is a cholecystokinin type 1 (CCK1) receptor inhibitor for inhibiting [125I]BH-CCK-8S with IC50 of 37.7 μM.
Signal Transduct Target Ther, 2021, 6(1):148
University of Alberta, 2014, Yahya Muhammad Fiteih
S9690 Caerulein (Cerulein, FI-6934) Caerulein (Ceruletide, Cerulein, FI-6934), a cholecystokinin (CCK) receptor agonist, is a safe and effective cholecystokinetic agent and small bowel and exocrine pancreatic stimulant. Caerulein (FI-6934) can be used to induce animal models of acute pancreatitis.
J Adv Res, 2025, S2090-1232(25)00225-5
J Gastroenterol, 2025, 10.1007/s00535-025-02323-y
P1249 Gastrin I, human Gastrin I, human is an important analogue of gastrin, an endogenous gastrointestinal peptide hormone. It plays key roles in digestion and energy homeostasis via CCK2 receptor activation in digestive processes including gastric acid secretion, pancreatic enzyme release, gallbladder emptying, gut motility.
E7316 Cholecystokinin Octapeptide, desulfated Cholecystokinin Octapeptide, desulfated, (CCK-8 (desulphated)) is a synthetic peptide lacking the sulfate group on its tyrosine residue, reducing its activity at CCK-A receptors while allowing selective binding to CCK-B receptors. It is used in research to study central and gastric effects mediated by CCK-B receptors, independent of digestive enzyme stimulation.
S6939 Nastorazepide Nastorazepide (Z-360), a cholecystokinin-2/gastrin receptor (CCK2/gastrin receptor) antagonist, combines with gemcitabine prolonged survival and reduces gemcitabine-induced vascular endothelial growth factor (VEGF) expression in a pancreatic carcinoma orthotopic xenograft mouse.